You're reading everything related to:

Growth of Medical Cannabis Sales in Germany is Faltering

New official data suggests that sales of medical cannabis in Germany have stagnated over recent quarters.

Expert Interview: Giorgio Ferdinandi, Chief Sales Officer, Linnea

Linnea’s mission is to improve the quality of life of people around the globe by manufacturing and distributing superior-quality purified and semi-synthetic APIs and standardized herbal extracts.

The Global Cannabis Legalisation Overview

We've taken a look back at some of the most significant legislative developments of 2021 and the current state of play for cannabis across different continents, as we look forward...

Cannabis Industry 2022: Trends, New Markets & Challenges

Prohibition Partners hosted the Cannabis Industry 2022: Trends, New Markets & Challenges webinar earlier this month, in partnership with Always Pure Organics.

Global Cannabis Sales Hit $37.4 Billion In 2021 - Rising To $102 Billion By 2026

Released today, The Global Cannabis Report: Second Edition provides an overview of the development of international cannabis markets, and considers how they might develop in the near future.

Poland Receives Its Largest Ever Shipment of Medical Cannabis

The largest ever shipment of medical cannabis has been delivered to the Central European nation, ending several months of supply droughts. While demand is growing rapidly, regulations continue to dampen...

The Next German Government Wants To Legalise Adult-Use Cannabis

The prospective ruling coalition in Germany wants to introduce legislation aimed at legalising adult-use cannabis in Germany, local media sources confirmed on Thursday.

Business of Cannabis: New York - The Industry Roundup

The State of Play sessions at Business of Cannabis: New York welcomed industry leaders to the stage to discuss the state of the market.

Business of Cannabis: New York - The Industry Roundup

The speakers of Business of Cannabis: New York discussed the opportunities, practicalities and obstacles of building a new market.

Business of Cannabis: New York - Social Equity Roundup

During two focused panels, speakers at Business of Cannabis: New York explored the issue at the centre of cannabis legalisation in New York - social equity.

Sales of Medical Cannabis in the Netherlands Decline in 2021

Conor O'Brien explores the possible causes of the decline in medical cannabis sales - and number of patients - in the Netherlands.

Business of Cannabis: New York - Keynote Roundup

The keynote speakers at Business of Cannabis: New York set the tone for a summit that focussed on the potential of a profitable and socially equitable cannabis industry in New...

"New York Cannabis Legalisation a Pivotal Moment for the Industry" - Leafly CEO

Ahead of Business of Cannabis: New York, leading cannabis industry experts and speakers share their thoughts on the future of cannabis in New York.

Is Cannabis the Future for Big Tobacco?

International cannabis expert, Barbara Pastori, shares her thoughts on why cannabis is a compelling case for big tobacco companies.

High Tide Announced as Sponsor of Business of Cannabis: New York

High Tide is an official sponsor of the Business of Cannabis: New York summit on September 29.

Vicente Sederberg Announced as Sponsor of Business of Cannabis: New York

Vicente Sederberg is an official sponsor of the Business of Cannabis: New York summit on September 29.

Fire & Flower US/B Cubed Announced as Sponsor of Business of Cannabis: New York

Fire & Flower US/B Cubed Cannabis is an official sponsor of the Business of Cannabis: New York summit on September 29.

Canadian Securities Exchange Announced as Official Sponsor of Business of Cannabis: New York

We’re pleased to announce that Canadian Securities Exchange is an official sponsor of the Business of Cannabis: New York summit on September 29.

Key Insights from The Pharmaceutical Cannabis Report: 2nd Edition

The use of cannabinoids in the treatment of medical conditions offers major opportunities, but also challenges, to anyone wishing to operate in this space. 

Conor Green Announced as Official Sponsor of Business of Cannabis: New York

We’re pleased to announce Conor Green is an official sponsor of the Business of Cannabis: New York summit on September 29.

Sales of Three Major Pharmaceutical Cannabis Products Set to Reach €1.8 Billion by 2025

Combined sales of the three most lucrative cannabis pharmaceuticals products - Epidiolex®, Dronabinol and Sativex® - are set to reach €1.8 billion by 2025, according to The Pharmaceutical Cannabis Report:...

The Pharmaceutical Cannabis Report: 2nd Edition - Launching Today

Prohibition Partners is proud to launch the The Pharmaceutical Cannabis Report: 2nd Edition.

Leafly Announced as Headline Sponsor of Business of Cannabis: New York

We’re pleased to announce Leafly is the headline sponsor of the Business of Cannabis: New York summit on September 29.

An interview with Robert Fonn of DLA Piper

Vitalis Extraction Technology Inc. is an engineering and manufacturing company, producing industrial supercritical CO₂ extraction systems for the cannabis, hemp, pharmaceuticals, F&B and botanical industries. Renowned for their reliability, scalability,...

An interview with Robert Fonn of DLA Piper

PurePressure provides premium solventless processing products and rosin presses to support any operation, big or small. Their rosin presses have legendary reputations for reliability, precision, and control.

Senator Liz Krueger to Detail ‘Nation-Leading’ Model for Cannabis Legalisation at Major Summit

Senator Liz Krueger will detail New York’s model for cannabis legalisation at the Business of Cannabis: New York summit on September 29 - the first major cannabis summit since the...

An interview with Robert Fonn of DLA Piper

Always Pure Organics is a specialist manufacturer and distributor of cannabis-based products and a sponsor of Prohibition Partners' recently-released The Cannabis Extraction Report.

Tokyo 2020: How Cannabis has Changed the Olympic Games

International cannabis expert Barbara Pastori explores the growing role that cannabis-based substances can play in sports, the regulatory barriers, possible opportunities, and the conversation around cannabis during the Tokyo 2020...

Medical Cannabis Access Progresses in Ireland

Micellae Delivery Systems Inc. has announced the launch of its breakthrough cannabinoid delivery technology, O2W.

Prohibition Partners Acquires Business of Cannabis

Acquisition of North American Publisher Creates the Leading B2B Media & Data Platform in Global Cannabis.

Medical Cannabis Access Progresses in Ireland

A new Medical Cannabis Access Programme is now in place and the Irish government will directly reimburse patients for medical cannabis products.

Senate Majority Leader Chuck Schumer introduces a bill to federally legalise cannabis in the United States

On Wednesday, 14 July, Senate Majority Leader Chuck Schumer released a draft bill that would federally legalise cannabis in the US.

Adult-Use Cannabis Legalisation in Europe: The Final Countdown Begins

In this insightful article, international cannabis expert, Barbara Pastori, explores the potential impact of adult-use legalisation in Europe.

Venue & Speakers Announced - Business of Cannabis: New York

In partnership with Business of Cannabis, we're pleased to announce that the secret venue for Business of Cannabis: New York can finally be revealed.

Uruguay is on the Cusp of Legalising and Commercialising CBD Edibles

The Uruguayan government is considering proposed changes to regulations which, if approved, will result in the legalisation of edible non-psychoactive cannabis products.

The Extraction Report: Exclusive Preview - Webinar

Prohibition Partners were joined by Always Pure Organics and Vitalis Extraction Technology for an exclusive preview of The Extraction Report on Wednesday 30 June. With the extracts market on the...

Business of Cannabis: New York - September 29 2021

License marks commencement of European cultivation activities for Symtomax in Portugal.

Business of Cannabis: New York - September 29 2021

We’re pleased to announce our first joint event in partnership with Business of Cannabis. The event will take place in New York this September and will bring together the most...

THC Content of Illicit Market Cannabis in Europe at an All-Time High

The EMCDDA’s European Drug Report 2021 highlights a significant increase in THC content of cannabis in Europe, as well as prevalent cannabis use amongst Europeans and an increase in home...

Cannabis and Hemp to Aid Argentina’s Economic Recovery?

Argentina is making steady progress in its quest to become synonymous with the cultivation of other plants besides its beloved Yerba Mate, namely cannabis and hemp.

Political Parties in Portugal Propose Adult-Use Cannabis Legalisation Bills in Parliament

Momentum towards adult-use legalisation is gathering pace across Europe.

The Future of Social Equity and Social Justice in Europe

At Prohibition Partners LIVE last month, an expert panel explored how a legal cannabis industry in Europe could look with a socially-focused approach to Cannabis. Watch and read insights from...

Is There a Doctor in the House? Patient Access to Medical Cannabis

Time and again, we hear stories from current and prospective patients airing grievances about the system, cost and products on offer - much of which could be alleviated through reform...

Czech Parliament advances bill to liberalise medical cannabis

On Wednesday the 2nd of June, the lower house of the Czech Parliament approved a bill of amendments to the country's laws governing the production and prescription of medical cannabis...

The Medical Cannabis Conundrum in Europe

Amidst a steady rise in demand in Europe, what are the medical cannabis opportunities and challenges for producers and distributors alike?

Curaleaf Holdings Across the Pond: Why Europe, Why Now?

Executive Chairman & Founder of Curaleaf, Boris Jordan, joined Financial Times Reporter, Patricia Nilsson, for a frank fireside discussion at Prohibition Partners LIVE last week. Buckle in to hear insights...

Spanish Government to Examine Benefits of Legalising Medical Cannabis

Today, the Comisión de Sanidad y Consumo (Spanish Congressional Health and Consumer Affairs Commission) voted to establish a subcommittee with the express purpose of exploring the potential of medical cannabis...

From Production to Politics: Prohibition Partners LIVE returns

The third edition of the premium virtual cannabis conference to bring together over 60 speakers and 500 delegates from all corners of the globe in a three-day deep dive into...

Revealed: The Canadian Cannabis Export Market for 2020

Data provided to Atalis by Statistics Canada reveal for the first time in-depth details of the cannabis produced and exported from Canada.

Who are the medical cannabis patients in Europe?

The European medical cannabis market is still in its infancy, with much work to be done before patient access catches up to the levels seen in North America.

Reimbursed sales of medical cannabis in Germany grew by 34% in 2020

The National Association of Statutory Health Insurance Funds (GKV), whose members insure 90% of the German population, have released data on reimbursed medical cannabis usage covering the entirety of 2020....

Key Insights from The European Cannabis Report: 6th Edition

Prohibition Partners explore the key insights from the European Cannabis Report: 6th Edition, providing detailed analyses on all aspects of the burgeoning industry from patient access and regulatory change to...

The medical cannabis market grew 30% in Italy in 2020

New data shows that the market for medical cannabis in Italy continued to grow in 2020 despite COVID-related disruptions. However, patient accessibility remains a major issue in the country.

An interview with Robert Fonn of DLA Piper

The European cannabis market is developing strongly. The latest projections indicate that it is expected to reach US$37 billion by 2027 from US$3,5 billion in 2019; it is anticipated to...

An interview with Robert Fonn of DLA Piper

Founded in 1978, Memery Crystal is an in- dependent, full service, partner-led law firm based in Fleet Street, London. The firm’s practice areas include Corporate, Real Estate, Banking & Finance,...

An interview with Robert Fonn of DLA Piper

PharmaHemp started to build an Active Pharmaceutical Ingredients (API) production plant in accordance with current European Union Good Manufacturing Practices (EU GMP), which will enable the company to expand into...

An interview with Robert Fonn of DLA Piper

An interview with Jonathan Nadler Co-Founder & MD of LYPHE GROUP a European medical cannabis clinical telehealth and dispensing ecosystem.

An interview with Robert Fonn of DLA Piper

An interview with Marianne Hundtofte Nielsen from Aurora Europe GmbH, the largest authorized importer, exporter, and distributor of medical cannabis in the European Union.

An interview with Robert Fonn of DLA Piper

With roots deeply embedded in the horticultural industry and over 40 years of biogenetic experience, Perfect Plants is a global leader in tissue culture production. Specialising in food and pharma...

An interview with Robert Fonn of DLA Piper

An interview with Michael Sassano CEO of Somai Pharmaceuticals an international company focused on the extraction of the Cannabis plant and making formulations for the EU market.

An interview with Robert Fonn of DLA Piper

An interview with associates of DLA Piper a global law firm with lawyers located in more than 40 countries.

An interview with Robert Fonn of DLA Piper

Pioneering European Cannabis Cultivation with LED Lighting Solutions: a Q&A with Fluence EMEA General Manager Timo Bonartz.

An interview with Robert Fonn of DLA Piper

Why, given the challenges involved, has Linnea decided add Cannabis to its portfolio? Over the last 40 years or so, Linnea SA has gained extensive experience in the manufacture of...

Join us for an overview of the key findings from The European Cannabis Report: 6th Edition

In what is an exciting time for the future of cannabis in the Europe, the latest Prohibition Partners report focusses on Europe a crucial part of the global industry map.

Swiss Government Releases Details on Adult-Use Cannabis Pilot Schemes

The Swiss Federal Office of Public Health (FOPH) has announced further draft details on the plans for legalised supply of adult-use cannabis under pilot schemes. Under the current plan, the...

Petcare CBD: Regulations and Research 

A rapadura é doce mas não é mole não - this Brazilian idiom, which can be translated as “panela is sweet but is not soft” expresses the idea that some...

IASP Raises Questions on Use of Medical Cannabis for Pain

In the context of the ongoing legalisation of medical cannabis around the globe, the International Association for the Study of Pain (IASP) has raised questions about the effectiveness of the...

Petcare CBD: Regulations and Research 

Following the publication of IMPACT: Disrupting Petcare, Prohibition Partners has highlighted the development of the research and regulations which has shaped the industry so far, and how it is set...

Epidiolex and the Challenge for the Medical CBD Market

The use of CBD is growing rapidly across international markets as millions of people are using CBD every year for a wide range of reasons, especially across high-income countries like...

Cannabis & Petcare: Trends, Consumer Behaviour and COVID-19

The CBD petcare market saw significant developments in the last few years with an increase in acquisitions and partnerships, the rise of pet humanisation, celebrities such as Martha Stewart launching...

Mexican congress approves adult-use cannabis law

There is a famous Mexican idiom that says “El que nace pa' tamal, del cielo le caen las hojas”, roughly translated to “The one that is born for tamale, the...

German Government Answers Questions on Medical Cannabis

On the 4th of March, the German Bundestag published the following parliamentary questions on the topic of medical cannabis along with the government’s responses.

Key Insights from The IMPACT SERIES: Disrupting Petcare

The CBD and wellness segment has seen significant growth in the last few years, with brands diversifying their product offerings in the food and beverage, supplement, and most recently, the...

Colombia To Promote International Cannabis Exports

Last week, the Colombian government announced a draft bill to export cannabis flower to international markets. In this special feature from Prohibition Partners, we examine the potential of the Colombian...

Canada’s Preference for Cannabis 2.0 Products Increases

In October 2019, Canada launched Cannabis 2.0 products, including cannabis-based edibles, vapes, beverages, oils and topicals. Investors anticipated that these new products would bring a new wave of investment and...

Germany Imports Record Volume of Medical Cannabis in 2020

An analysis of the Germany cannabis market has revealed that cannabis imports are at their highest level, and there is no sign of the trend slowing for Europe's largest cannabis...

Exclusive: Dutch Medical Cannabis Sales Decreased in 2020

For the first time in ten years, the total sales of Dutch medical cannabis decreased from one year to the next (2019 to 2020). While domestic cannabis sales grew by...

New Data Reveals Cannabis Consumption Rates Across Europe

Between the 3rd August and 15th September 2020, the European Commission carried out a survey of EU and UK inhabitants on their cannabis consumpion

An interview with Robert Fonn of DLA Piper

DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning itself to help...

Key Insights from the North American Cannabis Report

Enjoy an overview of The North American Cannabis Report: Second Edition as well as a selection of the highlights featured within the latest publication from Prohibition Partners.

Jazz Pharmaceuticals acquires GW Pharma in $7.2 billion deal

MGC Pharmaceuticals is set to become the first cannabis company to list on the London Stock Exchange, representing a watershed moment for the European cannabis market.

Jazz Pharmaceuticals acquires GW Pharma in $7.2 billion deal

Jazz Pharmaceuticals announced its acquisition of GW Pharmaceuticals in a US$7.2 billion deal, subject to regulator and shareholder approval.

Join us for an overview of the key findings from the North American Cannabis Report

In what is an exciting time for the future of Cannabis in the USA, the latest Prohibition Partners report takes a laser focus to a crucial part of the global...

Prohibition Partners' Top Ten Trends for 2021

Prohibition Partners' international team of analysts, consultants and thought-leaders have come together to analyse the top trends set to define the cannabis industry in 2021 and beyond.  From the impact of...

USA Gears Towards Federal Cannabis Reform

On 6th January 2021, it was announced that the Democrats won both US Senate run-off elections in Georgia. This was a significant win for Democrats who now hold a half...

German cannabis flower market contracts in Q3

The latest data for the German medical cannabis market shows that in the midst of COVID-19, quarterly growth is stalling. While the value of flower sale dropped, the sales of...

Investigating Cannabis for COVID-19

The most serious cases of COVID-19 arise from patients' overactive immune responses which damage their own organs. As cannabis and its constituent cannabinoids are powerful modulators of the immune response,...

US House Progresses Bill which would Federally Decriminalise Cannabis

The MORE act, if passed into law in the US, would result in major cannabis reform across the country. However, there are still a number of hurdles which need to...

Discover the latest Key Insights from the Germany: Cannabis and CBD Consumer Report

This week, Prohibition launched the Germany Cannabis and CBD Consumer Report, providing the most comprehensive look at consumers of cannabis and CBD in Germany to date.

The UN Votes to Recognise the Potential Medical value of Cannabis

The UN has just accepted recommendations made by the World Health Organisation which reschedule cannabis and cannabis related substances, effectively accepting the medical potential of cannabis.

The Latin America & Caribbean 2020 Report: Key Trends

Across the breadth of Latin America and the Caribbean (LAC), which covers more than 10,000 kilometers north to south, the cannabis industry has been emerging, or re-emerging as some would...

European Court of Justice Rules that CBD is not a narcotic

In a landmark case for CBD in Europe, the highest court of the EU has ruled that CBD is not a narcotic and that the principle of free movement of...

New player in the Spanish medical cannabis landscape

Spain was one of the first European countries to decriminalise the personal use and cultivation of cannabis for self-consumption. However, while cannabis is used by individuals and the regulation of...

The number of adults in US states with legal adult-use cannabis just jumped by 20%

The number of adults in US states with legal adult-use cannabis just jumped by 20%

Major wins for progressive drug policy have been achieved in this round of US elections. Six ballots have been approved by voters which open up access to legal cannabis. Oregon...

CBD: Synthetic or Natural?

Danish cannabis: despite rising sales of flower, product availability is still a major issue

While flower sales saw a new high of almost 2 million mg of cannabinoid sold in Q2 2020, the scarcity of extracts in the country has kept the market constrained,...

53% of voters in New Zealand Support Continued Prohibition of Adult Use Cannabis in Preliminary Count

While results are preliminary, it is unlikely that a majority Yes vote will be achieved in the final count next week.

Key Insights From The Pharmaceutical Cannabis Report

Key Insights From CBD: The Consumer Report

CBD: The Consumer Report is the latest release in the suite of Prohibition Partners’ market-leading consumer research reports, providing proprietary data on over 15,000 adults from seven key global markets,...

Synthetic cannabinoid firm’s stock tanks 77% after failed clinical trials

Corbus Pharmaceuticals, one of the leaders in the pharmaceutical cannabinoid industry takes a hit as their lead drug fails in advanced clinical trials.

Australian medical cannabis approvals rising despite COVID-19 disruptions

After a quarter of stalled growth, approvals for cannabis-based medicines via the SAS-B route is now accelerating once more.

Europe is recording one million cannabis offences a year

Drug offences involving cannabis are following a stable, albeit slightly rising trend in Europe, which registers over one million cannabis offences each year, despite the fact that over 25 million...

Product testing in Australia reveals inconsistencies over cannabinoid potency

Last Friday, Australian regulator TGA published test results on the most common medical cannabis products sold in Australia. Results, which showed 23% of products had cannabinoid levels which differed from...

Prohibition Partners LIVE returns this November with global cannabis conference

Cannabis market set to offer welcome relief during global recession

European Cannabis: Waking The Sleeping Giant

Until recently, the pharmaceutical approach to cannabis of most European regulations entailed a significant entry barrier and favoured a general state of supply crunch.

Prohibition Partners Interviews Pharmin’s CEO Ana Kobalia

Pharmin is a vertically integrated Uruguayan company, formed in June 2019 as a result of a transnational partnership of experienced and successful entrepreneurs. Today, the company is proud of its...

Germany: Insured medicinal cannabis sales worth €75 million in the first half of 2020

New data just released from the National Association of Statutory Health Insurance Funds (GKV) shows continued year on year growth of the German medicinal cannabis market, despite signs that growth...

Recreational cannabis projects beginning to emerge in Europe

Prohibitionist ideologies embedded in the international narcotic treaties have hampered the development of legal recreational cannabis programmes in Europe. However, we have seen the emergence of cannabis social clubs and...

Prohibition Partners interviews cannabinoid expert D'Arcy Bond from Newell Sciences

Newell Sciences is a fully integrated cannabinoid producer that delivers high quality cannabinoids to the global market. Prohibition Partners sits down with D’Arcy Bond, Director of Newell Sciences, to discuss...

US Congressional Committee Approves the Medical Cannabis Research Act

Key insights from THE IMPACT SERIES: Disrupting Food

Israeli cannabis patient numbers reach 60,000 as imports are on course to dominate domestic market

Cannabis patient numbers in Israel have reached a record high in 2020, breaking the 60,000 mark. However, compliance issues for local producers have hamstrung the domestic market with imports rising...

Medical cannabis patient numbers reach 20,000 in Brazil

Individual patient authorisations to import cannabis products into Brazil continue to surge, as shown by the most recent data provided by Brazilian health regulator ANVISA to Prohibition Partners.

Medical growers planning over 300 tonnes of European-grown cannabis

For the majority of the previous two decades, the Netherlands was responsible for the sole commercial cultivation of cannabis in Europe. Now, half a dozen European states produce cannabis for...

Clarification: Is Cannabis a Cure for COVID?

Currently, over 22 million people have been infected with COVID-19 worldwide and researchers estimate that it will take months before we have medicines that effectively treat or cure the virus...

European medical cannabis trade: Southern Europe becoming largest supplier

The rising demand for medical cannabis in Europe, driven primarily by maturing markets such as Germany, Italy and the Netherlands, has opened the door to new sources for medical cannabis...

Hemp farming in the US: total acreage shrinks for the first time

Is the age of exponential growth in hemp farming coming to an end? If so, what does this mean for the supply-demand balance of the CBD industry? With CBD gradually...

Over 30% of adults in Europe and North America willing to try infused beverages

Proprietary consumer surveys from Prohibition Partners show that a significant proportion of the adult populations in Europe’s major cannabis markets and North America are willing to try infused beverages.

July records largest single-month patient growth in Australia as authorisations surge

Earlier today, the TGA of Australia released data on medical cannabis authorisations for July, showing the largest single month increase in prescription approvals to date.

Social Listening: Positive sentiment dominant ahead of New Zealand referendum

Recent online sentiment analysis has suggested cannabis legislation is now being viewed favourably by citizens in New Zealand.

Argentina announces plans to broaden medical cannabis schemes

Argentina has drafted regulations to increase accessibility to medicinal cannabis in 2020, allowing more patients to get access.

Germany imports 4,126kg of medical cannabis during the first half of 2020

Yesterday, Germany’s BfArM released new data on medical cannabis imports from Q1 and Q2 2020, showing an increase of 16% in Q1 2020 and 32% in Q2 2020.

Canadian legal cannabis sales set to surpass CAD$2 billion in 2020 and outpace illegal production

According to StatsCan, Canadian retailers sold a record CAD$185.9 million worth of cannabis in May 2020.

FDA set to launch widespread CBD testing plan to tackle product inconsistencies

Earlier this month, the US FDA released data on the US CBD market as part of a review by the White House relating to cannabis and CBD research.

UK CBD market facing shake up as prices drop and premium CPG brands set to emerge

Over the last two years, the UK CBD market has enjoyed low barriers to entry, a lack of regulatory standards and extremely high premiums for inconsistent high street products.

Deputy Ministers submit proposal to legalise adult-use cannabis in Guernsey

Two Deputy Ministers have submitted proposals to fully legalise recreational cannabis, with the hope of implementing an operating model similar to the one used in Canada.

Medical Cannabis Prescriptions Grow 400% year-on-year in the Czech Republic

Czech Republic passes 1,000 monthly patients mark as flower prescriptions grow 400% year-on-year

Overcapacity continues to loom over the Canadian market despite players slashing costs

Despite increasing demand, both in the medical and adult-use markets, inventory figures continued to increase in tandem, leading to an oversupply in the Canadian market.

Cannabis 2.0 boosts legal cannabis sales in Canada

Health Canada has resumed the publication of monthly data on the Canadian market, showing a steady increase in medical cannabis sales since October 2019.

New Zealand: ‘yes’ vote holds small lead ahead of cannabis referendum

Opinion polls in New Zealand are showing a small lead for the ‘yes’ vote ahead of the referendum on adult-use cannabis legalisation to be held on September the 19th.

Black market cannabis seizures plummet as legalisation progresses in North America

The 2020 World Drug Report published by the United Nations Office on Drugs and Crime (UNODC) reveals that cannabis remains the controlled drug with the most global widespread use, estimated...

Medical cannabis approvals show triple-digit annual growth in Australia

Our proprietary consumer survey, conducted between March and May 2020, shows that over 15% of the Canadian adult population uses cannabis for medicinal reasons.

Key Insights from The Impact Series: Disrupting Drinks

Disrupting Drinks is the latest report in The Impact Series — Prohibition Partners’ suite of in-depth reports detailing the impact of cannabis across key consumer markets — and the first...

Medical cannabis approvals show triple-digit annual growth in Australia

The Australian medical cannabis scheme has experienced triple-digit annual growth since cannabis was rescheduled for human therapeutic purposes in 2016.

German cannabinoid sales climb to €15 million in March

The last data release by GKV, the public insurer reaching 90% of the German population, comes to confirm the ascendant trend of the German medical cannabis market, which has been...

Prohibition Partners Releases Disrupting Drinks

Leading cannabis market intelligence and strategic consultancy firm Prohibition Partners has launched Disrupting Drinks. The report is the first in our series of in-depth consumer research reports, offering a comprehensive...

Hemp and CBG: What Will The 2020 Consumer Look Like?

Cannabigerol (CBG) is a rising star within the hemp industry, tipped to follow in the footsteps of CBD as the next non-psychoactive cannabinoid to dominate the low-THC consumer market.

Key Insights from The Oceania Cannabis Report: Second Edition

The number of states, territories and countries with legal cannabis policies continues to grow year-on-year, and health agencies around the world are now granting approvals for various medical cannabis products....

Global Cannabis Industry Goes Online: Prohibition Partners LIVE brings together thousands of delegates from every corner of the globe

Prohibition Partners LIVE will provide one single digital platform that will host five separate conferences with over 4,000 delegates attending to experience thought-leading content, high-quality networking, engaging experiences and entertainment,...

Key Insights from The Oceania Cannabis Report: Second Edition

The Oceania Cannabis Report: Second Edition is the most extensive review of the cannabis sector in Australia, New Zealand and the surrounding islands. Launched last week, the report offers an...

Prohibition Partners: Oceania cannabis market could be worth US$1.55b

The legal cannabis market in Australia, New Zealand and the rest of Oceania is set to be worth $US1.55 billion by 2024, according to new research from leading cannabis market...

COVID-19: The turning point for global cannabis legalisation

As of Friday, 3 April 2020, there are over one million confirmed cases of coronavirus worldwide. Analysts from the IMF and UN are predicting a global recession will follow in...

INSIGHT: How COVID-19 Is Impacting The Cannabis Industry

As of 27 March, we have seen over 530,000 confirmed cases of coronavirus (COVID-19) across 199 countries. As the outbreak develops, Prohibition Partners is monitoring the situation and reporting on...

INSIGHT: The Coronavirus Pandemic and Cannabis Consumer Behaviour

As of 19 March 2020, the coronavirus (COVID-19) disease has swept through 169 countries, resulting in over 200,000 confirmed case reports worldwide. It has become the first disease outbreak since...

Prohibition Partners Releases PSYCH: The Psychedelics as Medicine Report

Leading cannabis market intelligence and strategic consultancy firm Prohibition Partners has today launched PSYCH: The Psychedelics as Medicine Report. The report is the latest in Prohibition Partners' suite of market-leading...

Key Insights from PSYCH: The Psychedelics as Medicine Report

After decades of association with the ‘hippie’ counterculture movement, psychedelics are now experiencing a period of renaissance, as the medical community investigates their potential use in treating a wealth of...

Key Insights from The European Cannabis Report: 5th Edition

The European Cannabis Report: 5th Edition is the most extensive review of the European cannabis sector published to date. Launched last week, the report contains in-depth analyses of the countries...

Is the slow pace of cannabis legalisation fuelling the black market?

Advanced research, clinical trials and passionate patients campaigns has helped to progress medical cannabis legislation on a global scale. Yet despite this, patients are seemingly continuing to turn to unregulated,...

Key Insights from The Impact Series: Disrupting Beauty

CBD cosmetics are turning heads inside the beauty industry, becoming the most disruptive force in the industry in the last two decades. The skyrocketing demand for CBD beauty products is...

Our Top Trend for 2020: Normalisation

At the end of last year, Prohibition Partners published an analysis of the cannabis trends that shaped 2019, and offered an assessment of what we might expect from the year...

Prohibition Partners to co-host Davos’ Cannabis Conclave 2020

Prohibition Partners is pleased to be co-hosting the second annual Cannabis Conclave in Davos, Switzerland, in partnership with the Consumer Choice Center. 

The cannabis trends that shaped 2019

In 2019 Prohibition Partners identified five mega trends that were shaping the international cannabis industry.

The UK Cannabis Report: Key Insights

To mark the anniversary of the United Kingdom legalising medicinal cannabis one year ago, Prohibition Partners has produced The UK Cannabis Report. The report examines the future challenges and opportunities...

Uncovering the Truth Behind The Global Cannabis Industry Slump

With stocks in the cannabis industry climbing to record highs at the end of last year, 2019 was supposed to be the most prosperous year yet for the cannabis industry....

Key insights from The New Normal Report

The New Normal Report: Signs of the Times’ launched yesterday, in association with Protein Agency, an exploratory report documenting the rise of cannabis and CBD products across a number of...

US Congressional Committee Approves Cannabis Legalisation Bill in Historic Vote

On Wednesday, 20 November, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act was passed through the House Judiciary Committee in the US, marking the first time that a congressional committee...

Key Insights from The Global Cannabis Report

The global legal cannabis market is forecast to be worth up to US$103.9 billion by the year 2024, driven, in the most part, by the burgeoning international medicinal cannabis market,...

The Germany Cannabis Report: Key Insights

Since legalising medical cannabis in 2017, Germany has become a leading power in the European cannabis industry and is set to become a behemoth in the global market in the...

The SAFE Banking Act passes the U.S House of Representatives

Earlier this month, The Secure and Fair Enforcement Banking Act was passed by the U.S House of Representatives. Here's what it means...

Zenabis CEO, Andrew Grieve, on North America cannabis market growth

Earlier this month, Zenabis Global supported Prohibition Partners with the launch of The North American Cannabis Report. The report arrives against a backdrop of increased transatlantic trade, regulatory change and...

Launching Today: The Cannabis Legal Report

The Cannabis Legal Report launches today against a backdrop of global regulatory change, as the international cannabis market begins to enter the mainstream. However, in a market worth a potential...

Greece green lights 26 medicinal cannabis licences

Greece has approved 26 licences for cannabis cultivation and processing facilities in the country, the government has confirmed.

Liberté, Égalité…Legality? French government edges towards cannabis reform

Last month one of France’s most influential think-tanks, the Conseil d’analyse économique (CAE), recommended not only that France legalise recreational cannabis use, but also that the government form a monopoly...

Gaps remain in Irish pilot programme despite first shipment of medical cannabis oil

Earlier this week, Tilray successfully delivered the first medical cannabis oil shipment to Ireland following the decision to launch a five-year medical cannabis access scheme.

Aurora wins race for Italian medical cannabis tender

Aurora Deutschland is on the brink of landing a government contract to supply medical cannabis to the Italian government, after the other three firms left in the running were eliminated...

Turkey cannabis cultivation targets international drug trafficking

Sitting on the fence between the gardens of Europe and Asia, Turkey is still streets away from the more liberal drug policies of its European neighbours. The good news for...

UK medicinal cannabis policy ‘failing patients’

MPs have said that the UK government is failing patients who are at risk and suffering without access to medicinal cannabis. They are calling for a full inquiry into the...

Capital & Cannabis Conference Europe arrives in London

Prohibition Partners has teamed up with IMN to host the first European Cannabis Capital Conference (IC3) next week, bringing together the industry’s top brands and thought leaders with an array...

Italy announces new medical cannabis tender

Update (10 July 2019): The four companies now under review by the Italian Military are Tilray, Medicinal Organic Cannabis Australia, Aurora and Canopy Growth. The companies in the tender are...

Italy’s top court bans cannabis light sales as sector feels political heat

Italy’s highest court has outlawed cannabis light sales, in a landmark ruling handed down on Thursday, stating it is a crime to market derivatives of cannabis.

Cannabis Patent Races: The rush to trademark nature

The race to patent intellectual property is a key mark of any emerging market, with patents widely recognised as the most viable way of securing future earnings and gaining a...

Three things we learned from The Asian Cannabis Report™

Asia’s medical cannabis market will be worth over US$5.8 billion by 2024 if a number of key markets introduce reform in the medium term. The figure comes from research gathered...

German cannabis cultivation licences awarded to Aphria, Aurora and Demecan

Germany has awarded three companies licences to cultivate medicinal cannabis, bringing the long-delayed tendering process that has stymied Europe’s largest market to an end.

Israeli cannabis market heats up as elections approach

“The cannabis industry is at a unique turning point, turning within a dramatically short time-frame from a pariah to a main-stage industry. Some 35 countries have already legalised cannabis to...

Lesotho cannabis licences, one small nation leading the African continent

In 2017 the Kingdom of Lesotho was the first African nation to legalise the cultivation and export of medical cannabis. As of next month it is set to issue its...

Africa cannabis market could be worth over $US 7.1 billion annually by 2023

Africa’s legal cannabis industry could be worth more than $US 7.1 billion annually by 2023 if legislation is introduced in a number of the continent’s major markets, according to research...

Brexit Takes a New Turn - But What Lies Ahead For the UK’s Legal Cannabis Industry?

With Parliament voting down both Theresa May’s negotiated deal with the EU and the prospect of a no-deal exit, the UK will now endure a further period of prolonged commercial...

South African government hints at compromise over cannabis deadlock

In September 2018, the Constitutional Courts of South Africa legalised the private use of recreational cannabis. The move went against government policy and the executive branch of the government has...

Four key learnings from Cannabis Europa Paris

On Friday 8th February, Cannabis Europa Paris brought together leading voices on medical cannabis from the worlds of politics, pharmaceuticals and industry to discuss developments in France and across Europe.

Greek market yet to deliver as cannabis firms remain stuck in the weeds

Greece’s government has been busy approving the first wave of licences for companies wanting to grow medicinal cannabis in the Hellenic Republic, but no business has yet acquired all three...

ECH, Grow and IPS create historic milestone

ECH, Grow Biotech and IPS Specials have created a historic milestone by importing the first bulk shipment of cannabis-based medicine to the UK, since the Home Office legalised medical cannabis...

Prohibition Partners recruit french regulatory advisor as tides turn on french cannabis debate

Prohibition Partners is delighted to announce that Paula Cazes will be joining the team as Regulatory Advisor and correspondent on the French cannabis market. Paula is an international lawyer, trained...

UK medicinal cannabis use hampered by lack of doctor training

The European Cannabis Report™ 4th Edition is the most extensive review to date of the European cannabis industry. It examines legislation, regulation, market size and market opportunities in 33 European...

Cannabis Europa to unlock French medical cannabis industry

Following a string of key developments in 2018, France has begun reviewing their existing conservative cannabis policy by establishing a committee to review the legal status of the medical cannabis...

UK medical cannabis is now legal, but what can we expect?

Medical cannabis is officially available in the UK today via prescription and millions of patients, who suffer from registered conditions that can be treated with cannabis, could qualify for treatment.

European presence expanded in Spanish cannabis capital

Prohibition Partners is delighted to launch its first overseas office in Barcelona, Spain. The office is run by Head of Consulting David Attwood, who recently joined the team and will...

Australia medical cannabis industry & New Zealand to take on the global market

Oceania is poised for big things in the global cannabis market with a regional industry that is estimated to be worth US$8.7 billion by 2028. With over 20 companies registered...

Canada makes history as first G7 country to fully legalise cannabis

It’s hard to think about a more significant date, in the long and arduous history of cannabis prohibition than October 17th, 2018. Today, Canada becomes the first G7 country in...

Latin America cannabis industry to be worth over $12.7 billion

Over the past 24 months, the Latin American cannabis industry has emerged from the shadows to command the attention of the international cannabis community as over ten major markets have...

High consumption and favourable legislation boost Italian cannabis market

As of September 2018, the Italian medical cannabis system is struggling to meet patient demand. In 2017, 300 patients applied for medical cannabis but, a year later, nearly 10,000 patients...

Regional complexity inhibiting the Spanish cannabis industry

Last year we examined the state of cannabis clubs in Catalonia. Historically a frontrunner in terms of both medical and recreational cannabis the region has blazed a trail in continental...

European legal cannabis market expected to exceed 115 BILLION by 2028

By 2028, the European cannabis market will be worth €115.7 billion, according to market intelligence and strategic consultancy firm, Prohibition Partners. The findings come from The 3rd Edition of The...

Cannabis Patient boom in Germany puts pressure on supply

Since March 2017, medical cannabis has been legal in Germany, launching a new domestic industry, and attracting the watchful eye of the global cannabis community. Previously, the state had only...

Dutch cannabis sector to take control back from the black market

Dutch cannabis laws are not without fault. Since the introduction of coffee shops in 1976, Amsterdam’s cannabis has been supplied by criminal organisations. Additionally, a lack of cannabis cultivation licences,...

Macedonia cannabis aims to become leading european cultivator

In February 2016, after six months of deliberation, Macedonia has pushed through legislation to legalise the use of medical cannabis. Since then Macedonia has set its sights on European expansion...

Government giving mixed signals on medical Romania cannabis legislation

Romania’s history has been full of rebounds, ebbs and flows of distress and productivity, often playing catch up to rejoin the socio-economic norms of mainstream Europe. Once a powerful hemp...

Cautious pilot scheme rolls out Luxembourg cannabis

Luxembourg, nestled between France, Belgium and Germany, has long suffered from the domination of neighbouring countries. The end result is a proud national motto “Mir wëlle bleiwe wat mir sinn”...

Turkey cannabis cultivation aims to combat international drug trafficking

Sitting on the fence between the gardens of Europe and Asia, Turkey is still streets away from the more liberal drug policies of its European neighbours. The good news for...

Cultivation laws inhibiting Slovenian cannabis treatments

Cannabis is regularly or occasionally used by 15 percent of Slovenian population and it’s estimated that 30,000 citizens self-medicate using cannabis extracts. However, only 160 patients choose to do so...

Serbian patients fight for cannabis reform

Serbia is the largest and most populous country of the former Yugoslavia. It is home to a strong pro-legalisation movement which is led by activists, patients and researchers. In this...

Portuguese Cannabis laws are holding back economic potential

Historically, Portugal is regarded as somewhat of a trailblazer when it comes to drug reform. Yet in the 15+ years that have followed, very little progress has been made and...

Is the Netherlands cannabis industry falling behind?

The New Opium Act was implemented in the Netherlands in 1976, which was to lead the way for the so called ‘Policy of Tolerance’. Initially, the policy was meant as...

British cannabis market could still dominate Europe’s legal industry

It is 50 years since the Summer of Love attempted to break down British cannabis prohibition. Thankfully the world's understanding and education of this hugely important plant has evolved significantly...

The Israel cannabis sector, a global leader

Israel has been a pioneer in the research and development of medical cannabis for decades. THC and the endocannabinoid system were first discovered there.

Is the French Cannabis sector falling behind Europe?

Eoin Keenan

What does the future hold for the Czech cannabis industry?

Eoin Keenan

Ireland cannabis legalisation hits roadblock in pursuit of medical classification

A Bill calling for the legalisation of medical cannabis in Ireland was rejected by the Oireachtas Health Committee in July over fears that it could potentially “decriminalise the recreational use...

Cannabis cigarettes.. a hit for Swiss supermarket chain

Coop, the Swiss supermarket chain, now stocks cannabis cigarettes high in CBD and initial sales have already been incredibly high.

Poland passes bill to legalise medical cannabis

Poland’s lower house of parliament (Sejm) has voted overwhelmingly in favour of making medical cannabis legal “under certain circumstances”.

Greece legalises cannabis for medical use

On June 30th, the Greek Prime Minister, Alexis Tsipras and Health Minister, Andreas Xanthos announced that Greece is to become the seventh European country to legalise cannabis for medical use.

Spanish region blazes the trail for cannabis legalisation

Following a petition which amassed over 60,000 signatures, the Catalonian Parliament decided to legalise the cultivation, consumption and distribution of cannabis throughout the autonomous Spanish region.

German Cannabis leads the European medical market

January 19th, 2017 saw a major development in Germany’s relationship with cannabis. German parliament unanimously voted to make it legal for doctors to prescribe cannabis-based treatments for ‘seriously ill’ patients.

The European Cannabis Report

The legal cannabis industry is the biggest potential new market in the world, with Europe’s recreational alone currently being valued at €18bn. The European Cannabis Report from Prohibition Partners is the first...

Could Italy fully legalise recreational cannabis use? [And what could it mean for the economy?]

In April, in an effort to develop attitudes towards cannabis even further, The Radicali Italiani Movement announced plans to introduce a bill that proposes the full legalisation of adult cannabis...




on the cannabis market

Our weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry.